A First-in-Human Single and Multiple Ascending Dose Study of MT-251
A First-in-Human Single and Multiple Ascending Dose Study of MT-251
Recruiting · NCT07423299 · Registry updated 2026-02-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-Human Single and Multiple Ascending Dose Study of MT-251 | Healthy Volunteers | Recruiting | Phase 1 | 2026-02-25 | NCT07423299 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mirador Therapeutics, Inc. | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mirador Clinical Department | San Diego | United States | 2 |